• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Seattle Genetics

Related Topics

  1. Biomarin Pharmaceutical
  2. Myriad Genetics
  3. Scientific Industries
  4. First Mariner Bancorp
  5. Human Genome Sciences
  6. Exelixis

Popular Topics

  1. Eagle Bulk Shipping
  2. Commercial Banks
  3. Emerging Markets
  4. European Union
  5. Interest Rate

Seattle Genetics

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

    Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

  2. BioTime Appoints Franklin Berger to Board of Directors

    BioTime Appoints Franklin Berger to Board of Directors

  3. Seattle Genetics , Inc. SGEN Q4 2011 Earnings Call Transcript

    Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Seattle Genetics Fourth Quarter 2011 Financial Results Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be opened for questions. This ...

  4. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

  5. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  6. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  7. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  8. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

  9. No Sign of Slowdown in Biotech M&A

    High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.

  10. Small Cap Picks for the Long Haul

    Wasatch Small Cap Growth's Jeff Cardon discusses some of the fund's longer-term holdings, investment criteria, and new purchases.

Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.